Cas 868209-75-0,4-Quinolinamine, 1-[3,5-bis(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydro-2-methyl-, (2S,4R)-

868209-75-0

Post Buying Request

Basic information

Product Name: 4-Quinolinamine, 1-[3,5-bis(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydro-2-methyl-, (2S,4R)-
Synonyms:
CAS NO:868209-75-0
Molecular Formula: C19H16F6N2O
Molecular Weight: 402.339
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-Quinolinamine, 1-[3,5-bis(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydro-2-methyl-, (2S,4R)-(CAS DataBase Reference)
NIST Chemistry Reference: 4-Quinolinamine, 1-[3,5-bis(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydro-2-methyl-, (2S,4R)-(868209-75-0)
EPA Substance Registry System: 4-Quinolinamine, 1-[3,5-bis(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydro-2-methyl-, (2S,4R)-(868209-75-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 868209-75-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

868209-75-0 Suppliers

Recommended suppliers

868209-75-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 868209-75-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,8,2,0 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 868209-75:
(8*8)+(7*6)+(6*8)+(5*2)+(4*0)+(3*9)+(2*7)+(1*5)=210
210 % 10 = 0
So 868209-75-0 is a valid CAS Registry Number.

868209-75-0Upstream product

868209-74-9 benzyl (2S,4R)-1-(3,5-bis(trifluoromethyl)benzoyl)-2-methyl-1,2,3,4-tetrahydroquinolin-4-ylcarbamate

868209-75-0Downstream Products

868209-75-0Relevant academic research and scientific papers

PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES

-

Page/Page column 234-236, (2008/06/13)

Disclosed herein are compounds represented by Structural Formula: (I) and (I-A). Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply "CRTH2" for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 868209-75-0